Mar 30, 2023 07:01AM
Mar 30, 2023 07:00AM
Dec 16, 2022 06:31AM
Dec 16, 2022 06:30AM
Dec 5, 2022 06:30AM
Nov 14, 2022 04:01PM
Nov 14, 2022 06:32AM Diffusion Pharmaceuticals (DFFN) Reports Significant Progress in its Strategic Review Process
Nov 14, 2022 06:30AM
Oct 25, 2022 06:30AM
Oct 25, 2022 06:30AM
Aug 11, 2022 06:48PM
Jul 26, 2022 07:30AM
Jun 23, 2022 07:31AM
Jun 23, 2022 07:30AM Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
May 18, 2022 07:30AM
May 12, 2022 04:05PM
Apr 11, 2022 07:20AM
Mar 21, 2022 07:22AM
Mar 21, 2022 07:20AM
Dec 20, 2021 07:02AM
Dec 16, 2021 08:59AM Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial
Dec 1, 2021 07:02AM
Dec 1, 2021 07:02AM
Nov 22, 2021 07:02AM
Nov 10, 2021 07:02AM
Aug 30, 2021 07:33AM
Aug 30, 2021 07:32AM
Sep 10, 2020 08:04AM Diffusion Pharmaceuticals (DFFN) Reports First Two Patients Dosed with TSC in COVID-19 Clinical Trial
Sep 10, 2020 08:00AM
Sep 1, 2020 04:03PM
Sep 1, 2020 04:02PM
Aug 10, 2020 08:00AM
Jul 27, 2020 08:03AM
Jul 27, 2020 08:00AM
Jul 7, 2020 08:06AM Diffusion Pharmaceuticals (DFFN) Announces IND Filing for International Phase 1b/2b COVID-19 Clinical Program with TSC
Jul 7, 2020 08:00AM
Jun 11, 2020 08:04AM
Jun 11, 2020 08:00AM
May 26, 2020 09:13AM
May 26, 2020 08:03AM
May 26, 2020 08:00AM
May 20, 2020 01:00PM Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market
May 20, 2020 08:00AM
May 18, 2020 09:06AM
May 18, 2020 09:05AM
May 11, 2020 04:11PM
May 5, 2020 08:07AM
May 5, 2020 08:00AM
Apr 27, 2020 08:11AM Diffusion Pharmaceuticals (DFFN) Reports Pre-IND Submission to FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19
Apr 27, 2020 08:00AM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All